Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Transplanted perivascular adipose tissue accelerates injury-induced neointimal hyperplasia: role of monocyte chemoattractant protein-1.

Manka D, Chatterjee TK, Stoll LL, Basford JE, Konaniah ES, Srinivasan R, Bogdanov VY, Tang Y, Blomkalns AL, Hui DY, Weintraub NL.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1723-30. doi: 10.1161/ATVBAHA.114.303983. Epub 2014 Jun 19.

2.

CD14 directs adventitial macrophage precursor recruitment: role in early abdominal aortic aneurysm formation.

Blomkalns AL, Gavrila D, Thomas M, Neltner BS, Blanco VM, Benjamin SB, McCormick ML, Stoll LL, Denning GM, Collins SP, Qin Z, Daugherty A, Cassis LA, Thompson RW, Weiss RM, Lindower PD, Pinney SM, Chatterjee T, Weintraub NL.

J Am Heart Assoc. 2013 Mar 8;2(2):e000065. doi: 10.1161/JAHA.112.000065.

3.

Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells.

Blomkalns AL, Stoll LL, Shaheen W, Romig-Martin SA, Dickson EW, Weintraub NL, Denning GM.

J Inflamm (Lond). 2011 Feb 25;8:4. doi: 10.1186/1476-9255-8-4.

4.

Crosstalk between perivascular adipose tissue and blood vessels.

Rajsheker S, Manka D, Blomkalns AL, Chatterjee TK, Stoll LL, Weintraub NL.

Curr Opin Pharmacol. 2010 Apr;10(2):191-6. doi: 10.1016/j.coph.2009.11.005. Epub 2010 Jan 7. Review.

5.

Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding.

Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, Rothenberg FG, Neltner B, Romig-Martin SA, Dickson EW, Rudich S, Weintraub NL.

Circ Res. 2009 Feb 27;104(4):541-9. doi: 10.1161/CIRCRESAHA.108.182998. Epub 2009 Jan 2.

6.

Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells.

Snyder GD, Oberley-Deegan RE, Goss KL, Romig-Martin SA, Stoll LL, Snyder JM, Weintraub NL.

Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2053-9. doi: 10.1152/ajpheart.91529.2007. Epub 2008 Mar 21.

7.

Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues.

Denning GM, Ackermann LW, Barna TJ, Armstrong JG, Stoll LL, Weintraub NL, Dickson EW.

Peptides. 2008 Jan;29(1):83-92. Epub 2007 Nov 17.

PMID:
18082911
8.

Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism.

Dickson EW, Hogrefe CP, Ludwig PS, Ackermann LW, Stoll LL, Denning GM.

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H402-8. Epub 2007 Oct 19.

9.

Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease.

Stoll LL, Denning GM, Weintraub NL.

Curr Pharm Des. 2006;12(32):4229-45. Review.

PMID:
17100625
10.

Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?

Denning GM, Stoll LL.

Pediatr Pulmonol. 2006 Jan;41(1):23-34. Review.

PMID:
16267824
11.
12.

Antioxidant effects of statins.

Stoll LL, McCormick ML, Denning GM, Weintraub NL.

Timely Top Med Cardiovasc Dis. 2005 Feb 4;9:E1. Review.

PMID:
15824760
13.

Antioxidant effects of statins.

Stoll LL, McCormick ML, Denning GM, Weintraub NL.

Drugs Today (Barc). 2004 Dec;40(12):975-90. Review.

PMID:
15645009
14.

Potential role of endotoxin as a proinflammatory mediator of atherosclerosis.

Stoll LL, Denning GM, Weintraub NL.

Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2227-36. Epub 2004 Oct 7. Review.

PMID:
15472123
15.

Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells.

Stoll LL, Denning GM, Li WG, Rice JB, Harrelson AL, Romig SA, Gunnlaugsson ST, Miller FJ Jr, Weintraub NL.

J Immunol. 2004 Jul 15;173(2):1336-43.

16.

Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells.

Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, McCormick ML, Sigmund CD, Tang C, Weintraub NL.

Circulation. 2004 May 11;109(18):2221-6. Epub 2004 Apr 26.

PMID:
15117840
17.

Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins.

Rice JB, Stoll LL, Li WG, Denning GM, Weydert J, Charipar E, Richenbacher WE, Miller FJ Jr, Weintraub NL.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1576-82. Epub 2003 Jun 19.

PMID:
12816876
18.

Activation of NAD(P)H oxidase by lipid hydroperoxides: mechanism of oxidant-mediated smooth muscle cytotoxicity.

Li WG, Stoll LL, Rice JB, Xu SP, Miller FJ Jr, Chatterjee P, Hu L, Oberley LW, Spector AA, Weintraub NL.

Free Radic Biol Med. 2003 Apr 1;34(7):937-46.

PMID:
12654483
19.

Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide.

Fang X, Weintraub NL, Oltman CL, Stoll LL, Kaduce TL, Harmon S, Dellsperger KC, Morisseau C, Hammock BD, Spector AA.

Am J Physiol Heart Circ Physiol. 2002 Dec;283(6):H2306-14. Epub 2002 Aug 22.

20.

Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells.

Fang X, Weintraub NL, Stoll LL, Spector AA.

Hypertension. 1999 Dec;34(6):1242-6.

PMID:
10601125
21.

14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells.

Fang X, Moore SA, Stoll LL, Rich G, Kaduce TL, Weintraub NL, Spector AA.

Am J Physiol. 1998 Dec;275(6):H2113-21. doi: 10.1152/ajpheart.1998.275.6.H2113.

PMID:
9843811
22.

Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells.

Denning GM, Wollenweber LA, Railsback MA, Cox CD, Stoll LL, Britigan BE.

Infect Immun. 1998 Dec;66(12):5777-84.

23.

L- and D-S-nitroso-beta,beta-dimethylcysteine differentially increase cGMP in cultured vascular smooth muscle cells.

Travis MD, Stoll LL, Bates JN, Lewis SJ.

Eur J Pharmacol. 1996 Dec 27;318(1):47-53.

PMID:
9007512
24.
25.

13-HODE increases intracellular calcium in vascular smooth muscle cells.

Stoll LL, Morland MR, Spector AA.

Am J Physiol. 1994 Apr;266(4 Pt 1):C990-6.

PMID:
8178971
26.
27.
28.

Interaction of lysophosphatidylcholine with aortic endothelial cells.

Stoll LL, Oskarsson HJ, Spector AA.

Am J Physiol. 1992 Jun;262(6 Pt 2):H1853-60.

PMID:
1621844
29.
30.

Effect of differentiation on platelet-activating factor metabolism in HL-60 cells.

Stoll LL, Yerram NR, Spector AA.

J Cell Sci. 1991 Sep;100 ( Pt 1):145-52.

31.
32.
33.

Polarity of arachidonic acid metabolism by bovine aortic endothelial cell monolayers.

Shasby DM, Stoll LL, Spector AA.

Am J Physiol. 1987 Nov;253(5 Pt 2):H1177-83.

PMID:
3120601
34.

Lipid transfer between endothelial and smooth muscle cells in coculture.

Stoll LL, Spector AA.

J Cell Physiol. 1987 Oct;133(1):103-10.

PMID:
3117805
35.

Free fatty acid release from endothelial cells.

Figard PH, Hejlik DP, Kaduce TL, Stoll LL, Spector AA.

J Lipid Res. 1986 Jul;27(7):771-80.

36.

Changes in serum influence the fatty acid composition of established cell lines.

Stoll LL, Spector AA.

In Vitro. 1984 Sep;20(9):732-8.

PMID:
6500611
37.

Prostaglandin production by 3T3-L1 cells in culture.

Hyman BT, Stoll LL, Spector AA.

Biochim Biophys Acta. 1982 Nov 12;713(2):375-85.

PMID:
6817806
38.

Accumulation of (n-9)-eicosatrienoic acid in confluent 3T3-L1 and 3T3 cells.

Hyman BT, Stoll LL, Spector AA.

J Biol Chem. 1981 Sep 10;256(17):8863-6.

39.

Essential fatty acid availability and prostacyclin production by cultured human endothelial cells.

Spector AA, Hoak JC, Fry GL, Stoll LL, Tanke CT, Kaduce TL.

Prog Lipid Res. 1981;20:471-7. No abstract available.

PMID:
7043481
40.

Retention of human skin fibroblast fatty acid modifications during maintenance culture.

Spector AA, Denning GM, Stoll LL.

In Vitro. 1980 Nov;16(11):932-40.

PMID:
7450783
41.

Effect of fatty acid modification on prostacyclin production by cultured human endothelial cells.

Spector AA, Hoak JC, Fry GL, Denning GM, Stoll LL, Smith JB.

J Clin Invest. 1980 May;65(5):1003-12.

Supplemental Content

Loading ...
Support Center